Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/42239
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia
Author: Stiles, M.
Sanders, P.
Disney, P.
Brooks, A.
John, B.
Lau, D.
Shashidhar
Wilson, L.
Mackenzie, L.
Young, G.
Citation: American Journal of Cardiology, 2007; 100(8):1249-1253
Publisher: Excerpta Medica Inc
Issue Date: 2007
ISSN: 0002-9149
1879-1913
Statement of
Responsibility: 
Martin K. Stiles; Prashanthan Sanders; Patrick Disney; Anthony Brooks; Bobby John; Dennis H. Lau; Shashidhar; Lauren Wilson; Lorraine Mackenzie; and Glenn D. Young
Abstract: Evidence from noninvasive studies suggests magnesium has a differential effect on atrioventricular nodal (AVN) pathways. To further explore the electrophysiologic effects of intravenous magnesium sulfate (MgSO(4)) on supraventricular tachycardia, with particular reference to AVN conduction pathways, we studied 23 patients with supraventricular tachycardia at the time of electrophysiologic study. Tachycardia cycle length; AH, HV, and VA intervals; anterograde and retrograde Wenckebach thresholds; slow and fast pathway effective refractory periods (ERPs); accessory pathway ERP; right atrial and ventricular ERPs; blood pressure; and serum magnesium were evaluated before and after administration of MgSO(4) during sustained tachycardia. AVN reentry was induced in 14 patients and atrioventricular reentry was induced in 9; 1 of the latter had dual AVN physiology with tachycardia using the slow pathway. Serum magnesium level increased from 0.88 +/- 0.11 to 1.79 +/- 0.14 mmol/L (p <0.0001). Magnesium increased tachycardia cycle length to a greater extent in those with dual AVN physiology than those without: 340 +/- 54 to 370 +/- 57 ms versus 347 +/- 29 to 350 +/- 30 ms (p = 0.01). This was associated with greater increase in AH interval in those with dual AVN physiology than in those without: 241 +/- 59 to 270 +/- 60 ms versus 144 +/- 16 to 140 +/- 20 ms (p = 0.003). Presence of dual AVN physiology was more frequently associated with reversion to sinus rhythm: 5 of 15 versus 0 of 8 (p = 0.06). MgSO(4) did not alter other measured parameters. In conclusion, magnesium increases tachycardia cycle length and AH interval in patients with dual AVN physiology through a dominant effect on the slow AVN pathway.
Keywords: Heart Conduction System; Atrioventricular Node; Humans; Tachycardia, Supraventricular; Magnesium Sulfate; Anti-Arrhythmia Agents; Electrocardiography; Infusions, Intravenous; Blood Pressure; Adult; Female; Male
Description: Copyright © 2007 Elsevier Inc. All rights reserved.
RMID: 0020073203
DOI: 10.1016/j.amjcard.2007.05.051
Description (link): http://www.elsevier.com/wps/find/journaldescription.cws_home/525048/description#description
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.